Syringe reuse has been linked to transmission of hepatitis B and C viruses, HIV, malaria.
In 1999, WHO and UNICEF began to address the spread of blood borne diseases through reuse of needles and syringes by recommending that auto-disable (AD) syringes be used for all immunizations. Since their introduction in the mid-1990s, AD syringes have been widely accepted and are now used to administer immunizations globally.
View BD immunization highlights (PDF)
What to look for when procuring Auto-Disable (AD) Syringes
Download Report (PDF) »
|
BD Uniject™ Auto-Disable Device In collaboration with USAID, WHO, and many others, PATH The BD Uniject device simplifies the act of giving an injection, makes the unsafe reuse of the syringe impossible, and reduces the burden on logistics systems by making medicament, needle, and syringe available at the same place and time. The device also helps eliminate the waste commonly associated with multidose vials. Today, the Uniject device is licensed to BD for commercial production and distribution. |
|
BD SoloShot™ and BD SoloShot™ Mini Auto-Disable Syringes Where multidose vials and syringes are indicated, BD SoloShot™ auto-disable syringes are ideal for large-scale immunization programs. Easy to use Designed with minimal dead space to reduce medication waste |
|
BD SoloMed™ Syringe The BD SoloMed™ syringe is intended for acute care facilities in |
|
BD Emerald™ PRO Reuse prevention syringe with a passive locking mechanism. Meets ISO 7886-4 Type 1B requirements for passive reuse prevention Available in various sizes to accommodate both injection and reconstitution needs |
MSS0168 07/2012